Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance

PLoS ONE(2022)10.1371/journal.pone.0270201Source: DataRank Database

Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 9.25)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Teona Avaliani ORCID,Mariam Gujabidze,Tinatin Bakuradze,Maia Kipiani,Shorena Sabanadze

Live enrichment

PubMed:35749509 PMC:PMC9232145 OpenAlex:https://openalex.org/W4283381697

National Institute of Allergy and Infectious Diseases

Grant: R03 AI139871

National Institute of Allergy and Infectious Diseases

Grant: K23AI103044

Fogarty International Center

Grant: D43TW007124

National Institute of Allergy and Infectious Diseases

Grant: K23AI144040

NIAID NIH HHS

Grant: P30 AI168386

Infectious Diseases Society of America

FWCI

9.25

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0270201&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0270201&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0270201

journalhttps://doi.org/10.1371/journal.pone.0270201

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35749509

Fields of Study

Infectious Diseases and TuberculosisBacterial Infections and VaccinesTuberculosis Research and Epidemiology

MeSH Terms

Antitubercular AgentsDrug ResistanceHumansMycobacterium tuberculosisRetrospective StudiesTuberculosis, MeningealHIV InfectionsTuberculosis, Multidrug-Resistant

Keywords

MedicineDrug resistanceTuberculosisInternal medicineRetrospective cohort studyDrugProportional hazards modelMulti-drug-resistant tuberculosisExtensively drug-resistant tuberculosisCohortMortality rateSurgeryPharmacologyMycobacterium tuberculosisPathology

Sustainable Development Goals

SDG 0: Good health and well-being

Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)